NovoCure Limited (FRA:038)
11.43
+0.49 (4.53%)
Last updated: Jan 6, 2026, 8:05 AM CET
NovoCure Revenue
NovoCure had revenue of $158.81M USD in the quarter ending June 30, 2025, with 5.62% growth. This brings the company's revenue in the last twelve months to $630.16M, up 14.58% year-over-year. In the year 2024, NovoCure had annual revenue of $605.22M with 18.82% growth.
Revenue (ttm)
$630.16M
Revenue Growth
+14.58%
P/S Ratio
2.52
Revenue / Employee
$423.49K
Employees
1,488
Market Cap
1.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 605.22M | 95.88M | 18.82% |
| Dec 31, 2023 | 509.34M | -28.50M | -5.30% |
| Dec 31, 2022 | 537.84M | 2.81M | 0.53% |
| Dec 31, 2021 | 535.03M | 40.67M | 8.23% |
| Dec 31, 2020 | 494.37M | 143.05M | 40.72% |
| Dec 31, 2019 | 351.32M | 103.25M | 41.62% |
| Dec 31, 2018 | 248.07M | 71.04M | 40.13% |
| Dec 31, 2017 | 177.03M | 94.14M | 113.57% |
| Dec 31, 2016 | 82.89M | 49.80M | 150.52% |
| Dec 31, 2015 | 33.09M | 17.60M | 113.60% |
| Dec 31, 2014 | 15.49M | 5.13M | 49.53% |
| Dec 31, 2013 | 10.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
NovoCure News
- 9 days ago - NovoCure: 2026 Pipeline Outlook Makes This Stock A Speculative Buy - Seeking Alpha
- 19 days ago - NovoCure (NVCR) Q4 2024 Earnings Call Transcript - The Motley Fool
- 19 days ago - NovoCure (NVCR) Q3 2024 Earnings Call Transcript - The Motley Fool
- 19 days ago - Novocure (NVCR) Q2 2025 Earnings Call Transcript - The Motley Fool
- 20 days ago - First Week of February 2026 Options Trading For NovoCure (NVCR) - Nasdaq
- 20 days ago - Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - Novocure (NVCR) Appoints New CEO Amid Leadership Change - GuruFocus
- 5 weeks ago - Novocure CEO Ashley Cordova Resigns; Frank Leonard Named Replacement - Nasdaq